Olekhnovich Evgenii I, Manolov Alexander I, Samoilov Andrey E, Prianichnikov Nikita A, Malakhova Maja V, Tyakht Alexander V, Pavlenko Alexander V, Babenko Vlad V, Larin Andrey K, Kovarsky Boris A, Starikova Elizaveta V, Glushchenko Oksana E, Safina Dilyara D, Markelova Maria I, Boulygina Eugenia A, Khusnutdinova Dilyara R, Malanin Sergey Y, Abdulkhakov Sayar R, Abdulkhakov Rustam A, Grigoryeva Tatiana V, Kostryukova Elena S, Govorun Vadim M, Ilina Elena N
Federal Research and Clinical Centre of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Kazan Federal University, Kazan, Russia.
Front Microbiol. 2019 Aug 27;10:1902. doi: 10.3389/fmicb.2019.01902. eCollection 2019.
The human gut microbiome plays an important role both in health and disease. Use of antibiotics can alter gut microbiota composition, which can lead to various deleterious events. Here we report a whole genome sequencing metagenomic/genomic study of the intestinal microbiota changes caused by (HP) eradication therapy. Using approaches for metagenomic data analysis we revealed a statistically significant decrease in alpha-diversity and relative abundance of due to HP eradication therapy, while the relative abundance of increased. We have detected changes in general metagenome resistome profiles as well: after HP eradication therapy, the group, and genes were overrepresented, while and genes were underrepresented. We have confirmed these results with genome-resolved metagenomic approaches. MAG (metagenome-assembled genomes) abundance profiles have changed dramatically after HP eradication therapy. Focusing on gene conferring resistance to macrolides, which were included in the HP eradication therapy scheme, we have shown a connection between antibiotic resistance genes (ARGs) and some overrepresented MAGs. Moreover, some strains isolated from stool samples obtained after HP eradication have manifested greater antibiotic resistance in comparison to other isolates, as well as the higher number of ARGs conferring resistance to macrolides and tetracyclines.
人类肠道微生物群在健康和疾病中均发挥着重要作用。使用抗生素会改变肠道微生物群的组成,进而可能导致各种有害事件。在此,我们报告一项关于幽门螺杆菌(HP)根除治疗引起的肠道微生物群变化的全基因组测序宏基因组/基因组研究。通过宏基因组数据分析方法,我们发现由于HP根除治疗,α多样性和特定菌属的相对丰度出现了统计学上的显著下降,而另一些菌属的相对丰度则增加了。我们还检测到总体宏基因组耐药组谱的变化:HP根除治疗后,特定菌属及相关基因的丰度过高,而另一些菌属及基因的丰度则过低。我们用基因组解析宏基因组方法证实了这些结果。HP根除治疗后,宏基因组组装基因组(MAG)的丰度谱发生了显著变化。聚焦于HP根除治疗方案中包含的赋予对大环内酯类抗生素耐药性的基因,我们发现抗生素耐药基因(ARG)与一些丰度过高的MAG之间存在关联。此外,从HP根除治疗后获得的粪便样本中分离出的一些菌株,与其他分离株相比,表现出更高的抗生素耐药性,以及更多赋予对大环内酯类和四环素类抗生素耐药性的ARG。